Last reviewed · How we verify
Mometasone Furoate Aqueous Nasal Spray
Mometasone Furoate Aqueous Nasal Spray is a Small molecule drug developed by Yingu Pharmaceutical Co., Ltd. It is currently FDA-approved. Also known as: NASONEX.
At a glance
| Generic name | Mometasone Furoate Aqueous Nasal Spray |
|---|---|
| Also known as | NASONEX |
| Sponsor | Yingu Pharmaceutical Co., Ltd |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- A Extension Clinical Study of TQC2731 Injection in the Treatment of Chronic Sinusitis With Nasal Polyps (PHASE2)
- Efficacy and Safety of Ganciclovir Capsules in the Treatment of Refractory Moderate-to-severe Allergic Rhinitis (NA)
- A Clinical Study of TQC2731 Injection in the Treatment of Chronic Rhinosinusitis With Nasal Polyps (PHASE2)
- Study of Bencycloquidium Bromide Nasal Spray in the Treatment of Moderate-severe Persistent Allergic Rhinitis (PHASE4)
- The Efficacy Of Elonide Nasal Corticosteroids In Managing Allergic Rhinitis (NA)
- Observation on the Efficacy and Mechanism of SLIT With Dust Mite Allergen for PAR (PHASE2, PHASE3)
- Follow-up Studies of Primary Snoring(PS) and Obstructive Sleep Apnea Hypopnea Syndrome(OSAHS) in Chinese Children
- Mometasone Furoate Aqueous (MK-0887/SCH 032088) Nasal Spray vs Placebo and FLONASE® in Seasonal Allergic Rhinitis Patients (I94-001) (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Mometasone Furoate Aqueous Nasal Spray CI brief — competitive landscape report
- Mometasone Furoate Aqueous Nasal Spray updates RSS · CI watch RSS
- Yingu Pharmaceutical Co., Ltd portfolio CI
Frequently asked questions about Mometasone Furoate Aqueous Nasal Spray
What is Mometasone Furoate Aqueous Nasal Spray?
Mometasone Furoate Aqueous Nasal Spray is a Small molecule drug developed by Yingu Pharmaceutical Co., Ltd.
Who makes Mometasone Furoate Aqueous Nasal Spray?
Mometasone Furoate Aqueous Nasal Spray is developed and marketed by Yingu Pharmaceutical Co., Ltd (see full Yingu Pharmaceutical Co., Ltd pipeline at /company/yingu-pharmaceutical-co-ltd).
Is Mometasone Furoate Aqueous Nasal Spray also known as anything else?
Mometasone Furoate Aqueous Nasal Spray is also known as NASONEX.
What development phase is Mometasone Furoate Aqueous Nasal Spray in?
Mometasone Furoate Aqueous Nasal Spray is FDA-approved (marketed).
Related
- Manufacturer: Yingu Pharmaceutical Co., Ltd — full pipeline
- Also known as: NASONEX
- Compare: Mometasone Furoate Aqueous Nasal Spray vs similar drugs
- Pricing: Mometasone Furoate Aqueous Nasal Spray cost, discount & access